When is pooled cryoprecipitate indicated and how should it be dosed?

Pooled Cryoprecipitate: Indications and Dosing

For adults with major hemorrhage and hypofibrinogenemia, administer 2 pools of cryoprecipitate (equivalent to 4 g fibrinogen) when fibrinogen levels fall below 1.5 g/L, or below 2.0 g/L in obstetric hemorrhage. 1

Primary Indications

Pooled cryoprecipitate is indicated specifically for hypofibrinogenemia with active bleeding, not for prophylactic correction of laboratory values. The key clinical scenarios include:

Major Hemorrhage Settings

• Trauma with massive transfusion: Maintain fibrinogen >1.5 g/L 1
• Obstetric hemorrhage: Higher threshold of >2.0 g/L required 1
• Cardiac surgical bleeding: Particularly when associated with cardiopulmonary bypass 1
• Disseminated intravascular coagulation (DIC): Only when fibrinogen <1.0 g/L with active bleeding 1

Other Bleeding Scenarios

• Combined liver and renal failure with bleeding 1
• Bleeding associated with thrombolytic therapy 1
• Advanced liver disease to maintain fibrinogen >1.0 g/L 1

Standard Dosing Protocol

Adult dose: 2 pools of cryoprecipitate (each pool contains 5 units = 100-200 mL total volume) 1

• Each pool provides approximately 2 g of fibrinogen
• Two pools deliver 4 g total fibrinogen replacement
• Each single unit contains 400-450 mg fibrinogen 1

Transfusion Ratio in Massive Hemorrhage

Recent evidence suggests optimal timing based on red blood cell (RBC) transfusion volume:

• Component-only resuscitation: Consider cryoprecipitate after 7 units of RBCs 2, 3
• Whole blood-incorporated resuscitation: Consider after 10 units 2
• Optimal ratio: 1 pooled unit of cryoprecipitate per 7-8 units of RBCs provides survival benefit 3

Critical caveat: Ratios >8:1 (RBC:Cryo) show no mortality benefit and should be avoided 3. This represents inadequate fibrinogen replacement.

Administration Guidelines

• Transfuse through standard blood giving set with 170-200 μm filter 1
• Storage: Frozen at -25°C; once thawed, keep at ambient temperature for maximum 4 hours 1
• Never refrigerate after thawing 1
• Must be administered within the 4-hour window after thawing

Monitoring and Repeat Dosing

Guide therapy by:

1. Laboratory fibrinogen levels (conventional testing)
2. Viscoelastic testing (ROTEM/TEG) when available 4

Viscoelastic Thresholds for Cryoprecipitate

• TEG: Functional fibrinogen maximal amplitude <20 mm 4
• ROTEM: FIBTEM CA5 <10 mm 4

Repeat doses should be guided by serial measurements, not given empirically.

Important Clinical Nuances

The Empiric High-Dose Controversy

The 2023 CRYOSTAT-2 trial (n=1604) demonstrated that early empirical high-dose cryoprecipitate (3 pools = 6 g fibrinogen) did NOT improve 28-day mortality in trauma patients compared to standard care 5. This challenges the practice of routine early administration without documented hypofibrinogenemia.

Clinical implication: Cryoprecipitate should be targeted to documented fibrinogen deficiency, not given empirically to all bleeding trauma patients. Use laboratory or viscoelastic testing to guide administration.

Whole Blood Impact

Patients receiving whole blood require cryoprecipitate later in resuscitation (after 10 units vs. 7 units with components only) 2. This reflects whole blood's inherent fibrinogen content delaying the need for supplementation.

Special Populations

• Pediatric patients born after 1996: Use cryoprecipitate made from non-UK sourced FFP with viral inactivation (methylene blue) to reduce variant Creutzfeldt-Jakob disease risk 1
• Available as single units (20-40 mL) for smaller children 1

Common Pitfalls to Avoid

1. Do not use cryoprecipitate for volume replacement - it is a concentrated coagulation factor product, not a volume expander
2. Do not give prophylactically before procedures in non-bleeding patients with isolated low fibrinogen
3. Do not underdose - ratios >8:1 RBC:Cryo provide no survival benefit 3
4. Do not delay beyond 4 hours post-thaw - product becomes ineffective
5. Do not use for warfarin reversal - prothrombin complex concentrate is indicated instead

Practical Algorithm

For major hemorrhage:

1. Activate massive transfusion protocol
2. Send fibrinogen level (or perform VHA if available immediately)
3. If fibrinogen <1.5 g/L (<2.0 g/L in obstetrics) with ongoing bleeding → transfuse 2 pools
4. Recheck fibrinogen after each 7-8 units of RBCs transfused
5. Repeat 2-pool doses as needed based on laboratory/VHA results

This targeted approach balances the need for fibrinogen replacement with evidence showing no benefit from empirical administration 5.